Intrathecal gentamicin in treatment of bacterial meningitis.
D001419:Bacteria / Q000302:isolation & purification; D001424:Bacterial Infections / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D005839:Gentamicins / Q000008:administration & dosage* / Q000009:adverse effects / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007278:Injections, Spinal; D007958:Leukocyte Count; D008297:Male; D008581:Meningitis / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D008875:Middle Aged; D011113:Polymyxins / Q000008:administration & dosage / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa; D012131:Respiratory Insufficiency / Q000139:chemically induced; D012640:Seizures / Q000139:chemically induced
D005839:Gentamicins; D011113:Polymyxins